Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 12:5:391.
doi: 10.3389/fimmu.2014.00391. eCollection 2014.

Immunity to HIV in Early Life

Affiliations
Review

Immunity to HIV in Early Life

Maximilian Muenchhoff et al. Front Immunol. .

Abstract

The developing immune system is adapted to the exposure to a plethora of pathogenic and non-pathogenic antigens encountered in utero and after birth, requiring a fine balance between protective immunity and immune tolerance. In early stages of life, this tolerogenic state of the innate and adaptive immune system and the lack of immunological memory render the host more susceptible to infectious pathogens like HIV. HIV pathogenesis is different in children, compared to adults, with more rapid disease progression and a substantial lack of control of viremia compared to adults. Plasma viral load remains high during infancy and only declines gradually over several years in line with immune maturation, even in rare cases where children maintain normal CD4 T-lymphocyte counts for several years without antiretroviral therapy (ART). These pediatric slow progressors also typically show low levels of immune activation despite persistently high viremia, resembling the phenotype of natural hosts of SIV infection. The lack of immunological memory places the fetus and the newborn at higher risk of infections; however, it may also provide an opportunity for unique interventions. Frequencies of central memory CD4+ T-lymphocytes, one of the main cellular reservoirs of HIV, are very low in the newborn child, so immediate ART could prevent the establishment of persistent viral reservoirs and result in "functional cure." However, as recently demonstrated in the case report of the "Mississippi child" who experienced viral rebound after more than 2 years off ART, additional immunomodulatory strategies might be required for sustained viral suppression after ART cessation. In this review, we discuss the interactions between HIV and the developing immune system in children and the potential implications for therapeutic and prophylactic interventions.

Keywords: HIV; adaptive immunity; immune activation; immune exhaustion; immune responses; innate immunity; pediatric; viral reservoir.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of components of the developing immune system in HIV infection. The developing immune system is characterized by an attenuated pro-inflammatory innate immune response with a shift toward Th2/Th17 polarizing cytokines to protect the organism against extracellular pathogens and reduce the risk of autoimmunity and inflammation. A tolerogenic state of the immune system is supported by increased frequencies of regulatory T-cells that suppress the activity of CD4 and CD8 T-cells. Microbial translocation and viral replication result in immune activation and immune exhaustion that lead to immune dysfunction and loss of immune control resulting in further viral replication in a positive feedback loop. Differences in target cell availability and memory differentiation in early life affect the size and composition of the viral reservoir in children. Main aspects of the developing immune system in regards to vertical HIV infection are summarized. Treg: regulatory T-cells; NK cell: natural killer cell; PAMPs: pathogen-associated molecular patterns; CTL: cytotoxic T-lymphocyte.

References

    1. Prendergast AJ, Klenerman P, Goulder PJ. The impact of differential antiviral immunity in children and adults. Nat Rev Immunol (2012) 12(9):636–4810.1038/nri3277 - DOI - PubMed
    1. Brenchley JM. Mucosal immunity in human and simian immunodeficiency lentivirus infections. Mucosal Immunol (2013) 6(4):657–6510.1038/mi.2013.15 - DOI - PMC - PubMed
    1. Khaitan A, Unutmaz D. Revisiting immune exhaustion during HIV infection. Curr HIV/AIDS Rep (2011) 8(1):4–1110.1007/s11904-010-0066-0 - DOI - PMC - PubMed
    1. Paiardini M, Muller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev (2013) 254(1):78–10110.1111/imr.12079 - DOI - PMC - PubMed
    1. Persaud D, Gay H, Ziemniak C, Chen YH, Piatak M, Jr., Chun TW, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med (2013) 369(19):1828–3510.1056/NEJMoa1302976 - DOI - PMC - PubMed